Jamilisse Segarra-Villafane
Endocrinology, Diabetes & Metabolism · Humacao, PRNPI 1396394870
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,556 of the $5,101 with a category attached, or 89.3%. It is spread thinly across 23 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,277, more than ten times the $20 reported in 2022. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in PR, where the typical reported total is $4,706.
Across 132 payments — averaging $38.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$819
- Boehringer Ingelheim$627
- Bayer$461
- Amgen$433
- Dexcom, Inc.$386
- Abbott$370
- plus $2K from 17 others
What the payments were for
- Travel & lodging$54511%
- Food & beverage$4,55689%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $819 |
| Boehringer Ingelheim | 19 | $627 |
| Bayer | 4 | $461 |
| Amgen | 12 | $433 |
| Dexcom, Inc. | 12 | $386 |
| Abbott | 11 | $370 |
| Corcept Therapeutics | 4 | $268 |
| Kyowa Kirin, Inc. | 2 | $245 |
| Eli Lilly Export S.A. Puerto Rico Branch | 9 | $212 |
| Bayer Puerto Rico Inc. | 10 | $185 |
| AstraZeneca | 8 | $166 |
| Lilly USA, LLC | 1 | $118 |
| BETA Bionics, Inc. | 1 | $116 |
| PBG Puerto Rico LLC | 6 | $113 |
| Novartis | 5 | $111 |
| Novo Nordisk | 5 | $109 |
| Rhythm Pharmaceuticals, Inc. | 3 | $77 |
| Perspectum Diagnostics Ltd | 1 | $73 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Radius Health, Inc. | 2 | $54 |
| Vifor Pharma, Inc. | 2 | $40 |
| AbbVie | 2 | $40 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$574
- Kerendia$366
- iLet Bionic Pancreas$347
- JARDIANCE$233
- Korlym$220
- FREESTYLE LIBRE 3$163
- Repatha$125
- DEXCOM G7 GSS (161)$121
- DEXCOM STELO GLUCOSE BIOSENSOR$121
- CRYSVITA$119
- ZEPBOUND$118
- iLet Insulin Infusion Kit Inset$116
- iLet Insulin Infusion Kit Contact Detach$116
- TEPEZZA$108
How this compares
$5,101 in reported general payments places this provider in the 50th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 24 | $16,439 |
| Jentadueto XrLinagliptin/Metformin Hcl | 19 | $11,112 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 14 | $6,684 |
| SynthroidLevothyroxine Sodium | 96 | $5,978 |
| JanumetSitagliptin Phos/Metformin Hcl | 17 | $5,755 |
| LantusInsulin Glargine,hum.Rec.Anlog | 35 | $2,846 |
| Cabergoline | 26 | $1,871 |
| Desmopressin Acetate | 16 | $1,112 |
| Hydrocortisone | 46 | $652 |
| Atorvastatin Calcium | 70 | $457 |
| Losartan Potassium | 55 | $348 |
| Rosuvastatin Calcium | 32 | $320 |
| Calcitriol | 16 | $301 |
| Alendronate Sodium | 20 | $111 |
| Lisinopril | 14 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $166 | $16,43924 claims |
| MerckJanumet Xr, Janumet | $20 | $12,43931 claims |
| Boehringer IngelheimJentadueto Xr | $627 | $11,11219 claims |
| AbbVieSynthroid | $40 | $5,97896 claims |
| Sanofi-aventis U.S. LLCLantus | $59 | $2,84635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in Humacao
- Myriam Allende-VigoHumacao$12K
- Jose Garcia MateoPonce$945K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Alex Gonzalez BossoloSan Juan$110K
- Michelle Mangual GarciaSan Juan$87K
- Meliza Martinez RodriguezSan Juan$80K
- Milliette Alvarado SantiagoRio Piedras$75K
- Altagracia Alcantara GonzalezBayamon$58K
- Jean Pujals KuryBayamon$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.